Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

MYCOBACTERIUM LEPRAE - ANVISA Registration 10269360345

Access comprehensive regulatory information for MYCOBACTERIUM LEPRAE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10269360345 and manufactured by QUIBASA QUÍMICA BÁSICA LTDA. The registration is held by QUIBASA - QUIMICA BASICA LTDA with validity until Aug 09, 2031.

This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including INSTITUTO DE BIOLOGIA MOLECULAR DO PARANÁ, MOBIUS LIFE SCIENCE INDÚSTRIA E COMERCIO DE PRODUTOS PARA LABORATÓRIOS LTDA, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
3 Competitors
4 Recent Registrations
10269360345
Registration Details
ANVISA Registration Number: 10269360345
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

BIOCLIN FAST ML FLOW HANSENÍASE
Risk Class III

Registration Details

10269360345

25351537347202197

19400787000107

Company Information

Brazil
PT: BRASIL

Dates and Status

Aug 09, 2021

09/08/2031

09/18/2025 19:00:01